ISSN 0564-3783  
Main page
Preview papers  
Information to authors
Editorial board
Standard version

In Ukrainian

Export citations   UNIMARC   BibTeX   RIS

Legal regulation of plant genome editing using the example of CRISPR/Cas9 technology

Medvedieva M., Blume Yа.


SUMMARY. The authors discover legal approaches to regulating the gene editing technology, in particular CRISPR/Cas9 technology: the product-oriented and the process-oriented approaches. Relevant legislation of the United States and the EU as well as some international treaties have been analyzed. The authors consider the issue of regulation of gene editing within the scope of GMO legislation or general legislation on risk assessment and risk regulation. The issue of patenting the technology of gene editing in the legislation of the United States, the EU, as well as under international law has been considered. The authors describe «patent wars» between the scientific teams of developers of CRISPR/Cas9 technology. The question of the possibility of obtaining patent protection for plants derived by means of geno-me editing technologies has been investigated.

Key words: genome editing, CRISPR/Cas9 technology, legal regulation, EU legislation, US legislation, international law, patents

Tsitologiya i Genetika 2018, vol. 52, no. 3, pp. 47-60

E-mail: medvedieva.maryna, blume.yaroslav

Medvedieva M., Blume Yа. Legal regulation of plant genome editing using the example of CRISPR/Cas9 technology, Tsitol Genet., 2018, vol. 52, no. 3, pp. 47-60.

In "Cytology and Genetics":
M. O. Medvedieva, Ya. B. Blume Legal Regulation of Plant Genome Editing with the CRISPR/Cas9 Technology as an Example, Cytol Genet., 2018, vol. 52, no. 3, pp. 204–212
DOI: 10.3103/S0095452718030106

Copyright© ICBGE 2002-2023 Coded & Designed by Volodymyr Duplij Modified 06.12.23